Articles with "prevalent new" as a keyword



Photo from wikipedia

Alternative analytic and matching approaches for the prevalent new‐user design: A simulation study

Sign Up to like & get
recommendations!
Published in 2022 at "Pharmacoepidemiology and Drug Safety"

DOI: 10.1002/pds.5446

Abstract: To describe the creation of prevalent new user (PNU) cohorts and compare the relative bias and computational efficiency of several alternative analytic and matching approaches in PNU studies. read more here.

Keywords: alternative analytic; analytic matching; matching approaches; prevalent new ... See more keywords
Photo from wikipedia

Initiator Types and the Causal Question of the Prevalent New User Design: A Simulation Study.

Sign Up to like & get
recommendations!
Published in 2020 at "American journal of epidemiology"

DOI: 10.1093/aje/kwaa283

Abstract: New user designs restricting to treatment initiators have become the preferred design for studying drug comparative safety and effectiveness using non-experimental data. This design reduces confounding by indication and healthy adherer bias at the cost… read more here.

Keywords: treatment; study; user design; prevalent new ... See more keywords
Photo by edhoradic from unsplash

Invited Commentary: The Prevalent New User Design in Pharmacoepidemiology: Challenges and Opportunities.

Sign Up to like & get
recommendations!
Published in 2020 at "American journal of epidemiology"

DOI: 10.1093/aje/kwaa284

Abstract: The prevalent new user design includes a broader study population than the traditional new user approach that is frequently used in pharmacoepidemiologic research. In an article appearing in this issue (Am J Epidemiol. XXXX;XXX(XX):XXXX-XXXX), Webster-Clark… read more here.

Keywords: user design; invited commentary; prevalent new; new user ... See more keywords

The prevalent new-user design for studies with no active comparator: The example of statins and cancer.

Sign Up to like & get
recommendations!
Published in 2023 at "Epidemiology"

DOI: 10.1097/ede.0000000000001628

Abstract: BACKGROUND Observational studies evaluating the effect of a drug versus "non-use" are challenging, mainly when defining cohort entry for non-users. The approach using successive monthly cohorts to emulate the randomized trial can be perceived as… read more here.

Keywords: design; prevalent new; user design; new user ... See more keywords